Breaking News, Collaborations & Alliances

India’s Top 11 Leading CRDMOs Join Forces to Launch IPSO

This collective initiative aims to advance India’s CRDMO sector and is dedicated to fostering pharmaceutical and healthcare innovation in India.

Author Image

By: Charlie Sternberg

Associate Editor

Left to Right: Mr. Vikash Agarwalla, MD & Partner, BCG, India; Peter Bains, CEO Designate, Syngene, India; Manni Kantipudi, CEO, Aragen Lifesciences; Nandini Piramal, Chairperson, Piramal Pharma Ltd; Giuliano Perfetti, Managing Director & CEO, Jubilant Biosys; Krishna Kanumuri, Managing Director & CEO, Sai Lifesciences; Akhil Ravi, CEO, Aurigene Pharmaceutical Services; Chandrasekhar, former Director of Indian Institute of Chemical Technology, Members of the BCG team.

In a step toward advancing India’s CRDMO sector, eleven of the country’s leading CRDMO companies have come together to launch a dedicated industry body called the Innovative Pharmaceutical Services Organization (IPSO), bringing together diverse expertise in discovery, development, biomanufacturing, and other specialized areas. This collective initiative aims to advance India’s CRDMO sector and is dedicated to fostering pharmaceutical and healthcare innovation in India that supports research, pol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters